Researchers in France are using tiny antibody particles extracted from the family of animals, including camels and llamas, to produce a test they say can detect if patients have COVID-19 faster and more accurately than existing methods, Reuters news agency reported on Tuesday.
This prototype test, called CorDial-1, has not been approved for use, but initial trials on 300 samples showed a 90% accuracy rate compared to a Polymerase Chain Reaction (PCR) test, the most reliable commonly-used method of detecting COVID-19.
According to the team developing this prototype test, it can deliver results within 10 minutes, and can be used outside the laboratory, while PCR testing typically takes hours and needs lab conditions.
The CorDial-1 test uses antibody fragments called nanobodies, which are derived from camelids, a group that includes camels, dromedaries, llamas and alpacas, because they are more stable than antibodies from other creatures.
For the COVID-19 test, the nanobodies are grafted onto the surface of an electrode. When those nanobodies come into contact with the "spike" protein of the COVID-19 virus, they interact to produce a change in the electrical current across the electrode.
When the testing apparatus, a device the size of a large USB stick, is plugged into a smartphone, the current shows up as a signal on a graph.
Sabine Szunerits, of the University of Lille, who is working on the project with scientists at the University of Marseille and the French National Centre for Scientific Research, said: "Depending on the height of the signal, you can say if you are COVID positive or negative."
The next phase of the project is to run a three-month trial on more than 1,000 people, Reuters added.
Crossject advances paediatric development of ZEPIZURE Junior for epilepsy crisis management
Creo Medical secures FDA clearance for SpydrBlade Flex in US market
Tissue Regenix secures CE and UKCA certifications for OrthoPure XT
Terumo Corporation expands stroke portfolio in EMEA with SOFIA Flow 88 catheter launch
Crossject advances ZENEO manufacturing with scalable aseptic filling module ahead of product rollout
ZYLOX Unicorn Vascular Closure Device approved in Indonesia
Mindray unveils BeneVision V Series at Euroanaesthesia 2025, advancing precision monitoring
Unicon Pharma and VRR Life Sciences partner support digital transformation in life sciences
Median Technologies submits 510(k) application for eyonis LCS lung cancer screening software